TRACY BRADY: Open Payments
NPI 1750137808 · LINDON, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$389 in 22 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $117 · 2025 $389
Food & beverage: $389
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 13 | $211 |
| Lilly USA, LLC | 2 | $40 |
| Tris Pharma Inc | 2 | $39 |
| Novo Nordisk Inc | 2 | $36 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $29 |
| Corium, LLC | 1 | $19 |
| Exact Sciences Corporation | 1 | $15 |
Products named: VRAYLAR, UBRELVY, MOUNJARO, Dyanavel XR, QULIPTA, CAPLYTA, Ozempic, Azstarys.
Industry payments across UT — which companies pay providers there.
